Rare Blood Cancer Complicates Recovery for Tennessee Death Row Survivor

Christa Pike is fighting a rare blood cancer that her lawyers warned could make her scheduled lethal injection exceptionally dangerous.

The 50-year-old convicted killer’s legal team filed a complaint on January 8, roughly nine months before her September 30 execution date. The filing stated that Pike’s platelet count is significantly elevated due to a condition known as myeloproliferative disorder. Her attorneys argued this thrombocytosis diagnosis increased the risk of severe pulmonary edema, a buildup of fluid in the lungs that can occur during lethal injections.

The complaint described the potential medical outcome as a sensation of suffocating or drowning. The lawyers likened this experience to waterboarding, calling it an unambiguous form of torture. They contended that the state’s plan violated the First, Eighth, and Fourteenth amendments because the procedure was very likely to result in unnecessary pain, terror, and disgrace.

Pike’s case has drawn national attention because she is the first death row inmate to survive a lethal injection. The botched execution involved two doses of pentobarbital administered with at least ten needles. She spent days unconscious and in critical condition in a hospital before returning to the Debra K. Johnson Rehabilitation Center ten days later.

She was poised to become the first woman executed in Tennessee in more than 200 years. According to the Cleveland Clinic, the specific cancer is not immediately fatal and is often manageable as a chronic condition for years. However, it can become life-threatening if it causes major blood clots or progresses into acute leukemia.

Pike remains in isolation at the rehabilitation center. In a statement released Friday, she described her current situation as being largely isolated in the prison’s medical ward. She noted that this separation places her away from other people and the human connections that mean so much to her.